A high throughputin vitromrp2 assay to predictin vivobiliary excretion
Authors:
- Catherine ArmstrongCACatherine Armstrong
- Jianmin DuanJDJianmin Duan
- Nathalie RiouxNRNathalie Rioux
- 2 October 2011
- journal article
- Published by Taylor & Francis in Xenobiotica
- Vol. 42 (2) , 157-163
Abstract
Prediction of biliary excretion is a challenge for drug discovery scientists due to the lack of in vitro assays. This study explores the possibility of establishing a simple assay to predict in vivo biliary excretion via the mrp2 transport system. In vitro mrp2 activity was determined by measuring the ATP-dependent uptake of 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) in canalicular plasma membrane vesicles (cLPM) from rat livers. The CDCF uptake was time- and concentration-dependent (K(m) of 2.2 ± 0.3 µM and V(max) of 115 ± 26 pmol/mg/min) and strongly inhibited by the mrp2 inhibitors, benzbromarone, MK-571, and cyclosporine A, with IC(50) values ≤ 1.1 µM. Low inhibition of CDCF uptake by taurocholate (BSEP inhibitor; 57 µM) and digoxin (P-gp inhibitor; 101 µM) demonstrated assay specificity towards mrp2. A highly significant correlation (r(2) = 0.959) between the in vitro IC(50) values from the described mrp2 assay and in vivo biliary excretion in rats was observed using 10 literature compounds. This study demonstrated, for the first time, that a high throughput assay could be established with the capability of predicting biliary excretion in the rat using CDCF as a substrate.Keywords
This publication has 26 references indexed in Scilit:
- Development of a fluorescence-based assay for drug interactions with human Multidrug Resistance Related Protein (MRP2; ABCC2) in MDCKII-MRP2 membrane vesiclesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- A Caco-2 cell based screening method for compounds interacting with MRP2 efflux proteinEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Involvement of Multiple Transporters in the Hepatobiliary Transport of RosuvastatinDrug Metabolism and Disposition, 2008
- Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injuryJournal of Gastroenterology and Hepatology, 2008
- Effect of Plasma Protein Binding on in Vitro-in Vivo Correlation of Biliary Excretion of Drugs Evaluated by Sandwich-Cultured Rat HepatocytesDrug Metabolism and Disposition, 2008
- Characterization of 5(6)-Carboxy-2,′7′-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4SLAS Discovery, 2008
- Methods To Evaluate Biliary Excretion of Drugs in Humans: An Updated ReviewMolecular Pharmaceutics, 2006
- Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in ratXenobiotica, 2002
- Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver.Journal of Cell Biology, 1984